Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference19 articles.
1. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK;Shaw;J. Clin. Oncol.,2009
2. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin;Oser;Lancet Oncol.,2015
3. Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK -rearranged lung cancer;Gainor;Cancer Discov.,2016
4. Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer;Doebele;Clin. Cancer Res.,2012
5. Next-generation sequencing reveals a novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/ RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib;Ignatius Ou;J. Thorac. Oncol.,2014
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC;Expert Review of Anticancer Therapy;2024-04-21
2. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation;Journal of Experimental Medicine;2024-01-29
3. Rebiopsie tumorale : quand ? pour qui ? pourquoi ? comment ?;Revue des Maladies Respiratoires Actualités;2023-10
4. ALK-Positive Adenocarcinoma After Acquired Resistance to Lorlatinib and Transformation to SCLC: A Case Report;JTO Clinical and Research Reports;2023-02
5. Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer;Molecular Biomedicine;2022-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3